Tuesday, March 29, 2011

29th of March 2011 - Technical Forex Market Overview

DAILY MARKET COMMENTARY
29 March 2011 – 8:00 GMT
Tuesday

_____________________________________________________________________
Market Analysis Desk
Foreign Exchange Research: www.fibosignals.com/5585/resources.html
_____________________________________________________________________


TECHNICAL DATA

USDJPY eyes 82.01.

EURUSD BULLISH Initial resistance is at 1.4194; break above this would expose 1.4249/82 zone. Support lies at 1.3981.

USDJPY NEUTRAL The pair eyes 82.01; a break here would expose 82.45. Initial support lies at 80.69.

GBPUSD BEARISH Push through 1.5977/64 support area has exposed 1.5873 ahead of 1.5822. Resistance is at 1.6142.

USDCHF NEUTRAL Recovery through 0.9317 would open 0.9369; break below 0.9076 would instead expose 0.8964.

AUDUSD BULLISH Positive momentum; move above 1.0315 would expose 1.0400/25. Near-term support is at 1.0187.

USDCAD BEARISH Fall through the initial support at 0.9705 would expose 0.9668 key low. Resistance at 0.9844.

EURCHF BULLISH Break through 1.3004/40 area would signal scope for gains towards 1.3138. Support is at 1.2788/36.

EURGBP BULLISH Move above 0.8820 would expose 0.8885. Near-term support is at 0.8740.

EURJPY BULLISH Pressures 115.57; a break would open 116.00/68 resistance area. Support lies at 113.56.


SCHEDULE

Please visit Fibosignals.com’s Economic Calendar for a schedule of market news and events.

A. White
Analyst at Fibosignals.com

DISCLAIMER: Fibosignals.com’s Daily Market Commentary is provided for informational purposes only. The information contained in these reports is gathered from reputable news sources and is not intended to be used as investment advice. Fibosignals.com assumes no responsibility or liability from gains or losses incurred by the information herein contained. Opinions, conclusions and other information expressed in this message are not given or endorsed by Fibosignals.com unless otherwise indicated by an authorized representative.

No comments:

Post a Comment